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Haraldur Bjarnason, MD,b Manju Kalra, MBBS,a Gustavo S. Oderich, MD,a
and Thomas C. Bower, MD,a Rochester, Minn
Objectives: To identify factors affecting long-term outcome after open surgical reconstructions (OSR) and hybrid
reconstructions (HR) for chronic venous obstructions.
Methods: Retrospective review of clinical data of 60 patients with 64 OSR or HR for chronic obstruction of iliofemoral
(IF) veins or inferior vena cava (IVC) between January 1985 and September 2009. Primary end points were patency and
clinical outcome.
Results: Sixty patients (26 men, mean age 43 years, range 16-81) underwent 64 procedures. Ninety-four percent had leg
swelling, 90% had venous claudication, and 31% had active or healed ulcers (CEAP classes: C3  30, C4  12, C5  8,
C6  12). Fifty-two OSRs included 29 femorofemoral (Palma vein: 25, polytetrafluoroethylene [PTFE]: 4), 17
femoroiliac-inferior vena cava (IVC) (vein: 3, PTFE: 14) and six complex bypasses. Twelve patients had HR, which
included endophlebectomy, patch angioplasty, and stenting. Early graft occlusion occurred after 17% of OSR and 33%
HR. Discharge patency was 96% after OSR, 92% after HR. No mortality or pulmonary embolism occurred. Five-year
primary and secondary patency was 42% (95% confidence interval [CI] 29%-55%) and 59% (CI 43%-72%), respectively.
For Palma vein grafts it was 70% and 78%, for femoroiliac and ilio-infrahepatic IVC bypasses it was 63% and 86%, and for
femoro-infrahepatic IVC bypasses it was 31% and 57%, respectively. Complex OSRs and hybrid procedures had 28% and
30% 2-year secondary patency, respectively. The only factor that significantly affected graft patency in multivariate
analysis was May-Thurner syndrome with associated chronic venous thrombosis. For HR, stenting into the common
femoral vein patch vs iliac stents only significantly increased patency. At last follow-up, 60% of the patients had no venous
claudication and no or minimal swelling. All ulcers with patent grafts healed but 50% of these recurred.
Conclusions: Both OSR and HR are viable options if endovascular procedures fail or are not feasible. Palma vein bypass
and femoroiliac or iliocaval PTFE bypasses have excellent outcomes with good symptomatic relief. ( J Vasc Surg 2011;53:
383-93.)
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nChronic venous obstruction of the iliofemoral veins
with or without associated inferior vena cava (IVC) throm-
bosis can lead to disabling venous claudication, severe
swelling, and ulceration causing disability. These patients
have a poor quality of life and are a burden to society
because of lost working days and the cost of medical care.1,2
Although conservative management with compression
and elevation is the first line of treatment, results in those
with chronic pelvic obstructions are rarely satisfactory. Al-
though many patients spontaneously recanalize venous
segments or develop collaterals; the process is unpredict-
From the Division of Vascular and Endovascular Surgery,a and the Division
of Interventional Radiology,b Gonda Vascular Center, Mayo Clinic.
Current address for Dr Karimi is CovenantMedical Center, Waterloo, Iowa.
Competition of interest: none.
Presented at the Thirty-fifth Annual Spring Meeting of the Peripheral
Vascular Surgery Society, during the 2010 Vascular Annual Meeting,
Boston, Mass, June 10-13, 2010.
Reprint requests: Peter Gloviczki, MD, Division of Vascular and Endovas-
cular Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
(e-mail: gloviczki.peter@mayo.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00t
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.08.086ble and incomplete. Patients who are young and active will
reatly benefit from interventions to establish venous out-
ow from the affected limb for optimal clinical outcome,
mprovement in their quality of life, and return to full
ctivity. Compression with surgical treatment for superficial
ein incompetence has been effective in decreasing ulcer
ecurrence in those without pelvic vein obstruction.3 Treat-
ent of proximal obstruction is important for patients with
dvanced disease, and successful iliofemoral reconstruction
mproves infrainguinal venous insufficiency.4
Open surgical reconstructions are challenging and pa-
ency is affected by the type of conduit, graft material, low
enous pressure, and thrombophilia that is frequently
resent in these patients.5 Endovascular venous stenting
s now proposed to be the first option for intervention
ith excellent midterm and some long-term results in
hronic symptomatic venous obstructions.6 Results are
etter for patients with non-thrombotic venous obstruc-
ions, such as the May-Thurner syndrome.6 Patients with
ostthrombotic etiologies have an occlusion rate of ap-
roximately 14% with an additional 10% of patients
eveloping severe in-stent restenosis at 5 years despite
epeat interventions.6 Patients with long segment ve-
ous obstruction, trauma, or prior surgical ligation of
he pelvic veins are poor candidates for endovascular
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February 2011384 Garg et alrecanalization and stenting. Endovascular recanalization
and stent placement also appear less successful in patients
with long, femorocaval venous obstructions.7 For some
patients, open surgical or hybrid reconstructions are the
only options for treatment. Our initial report with venous
reconstruction showed favorable early and midterm re-
sults.8,9 In this study, we examined factors affecting long-
term outcomes of open surgical reconstructions (OSR) and
hybrid reconstructions (HR) of iliofemoral (IF) veins and
the IVC at our institution.
METHODS
Retrospective review of clinical data of all patients who
were surgically treated at Mayo Clinic, Rochester, Minn,
between January 1, 1985 and September 30, 2009, for
nonmalignant obstruction of the IF veins and the IVC.
Short and midterm data on 27 of these patients were
previously reported.9,10
Venous reconstructions in patients treated for isolated
valvular incompetence, acute venous injury, and venous
resection related to malignancy were not included in this
report. Patients treated with venous endophlebectomy and
patch angioplasty for short obstructions were also ex-
cluded. Primary end points were long-term patency and
Fig 1. Palma procedure. A 38-year-old male with histor
ulcers, swelling, and venous claudication. A, Contrast ven
attempts at endovenous recanalization had failed. B, Rig
(GSV) (Palma procedure) was performed. C, Computed
bypass. Reproduced with permission of the Mayo Clinicclinical symptoms on long-term follow-up. Patency was tased on the last imaging by ultrasound, computed tomo-
raphic venography (CTV), or magnetic resonance venog-
aphy (MRV).
echnique
Femoral crossover bypass (Figs 1-3). Palma proce-
ure (suprapubic transposition of the great saphenous vein
GSV] with saphenofemoral anastomosis) is used for unilat-
ral iliofemoral obstruction. Contralateral GSV is harvested
with open or endoscopic technique) and tunneled subcuta-
eously in the suprapubic area to the groin incision of the
ffected limb. End-to-side anastomosis is performed between
he saphenous vein and ipsilateral common femoral vein. This
nastomosis can be spatulated onto the ipsilateral GSV if the
emoral or deep femoral veins are diseased and the GSV is the
redominant outflow in the affected leg. In postthrombotic
atients, inflow can be helped by excision of the recanalized
ld thrombus (endophlebectomy) in the femoral vein. An
xternally supported 10- to 12-mm diameter PTFE graft
prosthetic “Palma” procedure) is used if the GSV is inade-
uate (5 mm in diameter or of poor quality). An arterio-
enous (AV) fistula is performed between the GSV or pros-
hetic graft, and ipsilateral superficial femoral artery either
sing one of the side branches of the vein or a 4  7 mm
osttraumatic deep vein thrombosis (DVT) had right leg
m shows chronic right iliofemoral obstruction. Multiple
-left femoral vein bypass with left great saphenous vein
ographic (CT) venogram at 2 months revealed a patenty of p
ogra
ht-to
tomapered PTFE graft. The fistula is markedwith a silastic sheath
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Volume 53, Number 2 Garg et al 385for easy identification at a later time. We performed an AV
fistula for all prosthetic femorofemoral bypasses and selectively
in patients with vein (Palma) grafts if the vein was relatively
small (5mm) or if pressure gradient between the right and left
femoral veins was minimal (2 mmHg). In addition, an AV
fistula was added if we had to reoperate for early rethrombosis
and no fistula was used at the time of the first procedure.
Femoroiliac or iliocaval bypass (short bypass). Femo-
roiliac bypass was performed for isolated external iliac vein
or common femoral vein obstruction, using a vertical
groin and a retroperitoneal flank incision. For common
iliac vein obstruction alone or in conjunction with proximal
external iliac vein and/or distal IVC occlusion, bypass from
external iliac vein to the infrarenal IVC was performed
using a flank or midline incision. These “short” bypasses
(considered a distinct subgroup because of their hemody-
namic advantage) were performed using either autologous
straight or spiral vein graft or externally supported PTFE
(10-14mm). Short femoroiliac bypass is indicated if there is
not a good saphenous vein for Palma procedure, the com-
mon iliac vein is widely patent, or in patients with contralat-
eral venous occlusive disease.
Femorocaval or complex bypass (Figs 4 and 5). Unilat-
eral femorocaval bypass was performed on symptomatic
Fig 2. Femorofemoral crossover (“Palma” prosthetic) b
iliofemoral deep vein thrombosis (DVT) presented wi
occluded venous stent that could not be recanalized. B,C
common femoral vein (CFV).C, Left-to-right femoral ve
(prosthetic “Palma” procedure) was performed, with a lef
fistula (arrow).D,Computed tomographic (CT) venogra
image demonstrating the bypass and previous occluded
symptoms at last follow-up. Reproduced with permissionextremity or in a staged fashion for bilateral disease for dbstruction of the entire iliac segment and distal IVC using
2 to 14 mm externally supported PTFE grafts. Patients
ith bilateral disease or those with obstruction of suprare-
al or suprahepatic IVC underwent a complex reconstruc-
ion using either a bifurcated graft or tube graft with
ontralateral jump graft.
Hybrid reconstruction (Fig 6). In patients with
ommon femoral vein obstruction and proximal disease,
ndovenous recanalization with stent placement and fem-
ral vein endophlebectomy and patch angioplasty were
erformed simultaneously. Balloon angioplasty and stent-
ng was performed prior to or at completion of the patch
ngioplasty. In case of bilateral disease, open venous stent-
ng was performed on the side of obstructed common
emoral vein and contralateral side was percutaneously ac-
essed. Jugular vein access was obtained for antegrade
ecanalization as an alternative to or in combination with
emoral access. The stent was extended proximally to the
ealthy vein and across the inguinal ligament distally. In
ome cases, the stent was left just proximal to the femoral
enous surgical site, and in other cases, the stent was placed
nto the venous patch.
Telephone interviews were conducted to assess clinical
utcome in all patients who did not have a follow-up visit
. A 41-year-old male with history of posttraumatic left
ronic venous ulceration. A, Venogram demonstrating
ic scarring and postthrombotic changes noted in the left
pass with 12 mm ringed polytetrafluoroethylene (PTFE)
rficial femoral artery (SFA) to graft arteriovenous (AV)
rformed at 1 year revealed a patent bypass. E, Schematic
The patient’s ulcer healed and he had minimal residual
he Mayo Clinic.ypass
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February 2011386 Garg et alpatency on last follow-up who could not be contacted were
considered lost for clinical follow-up.
Survival analysis curves and log-rank test were used
to estimate and compare patency with 95% confidence
intervals (CI). Multivariate analysis for factors affecting
patency was performed using Cox-proportional hazards
method (using Mantel-Cox correction). The 2 test with
Fischer exact or Mantel-Hanzel odds were used to ana-
lyze symptom outcomes. Analysis was performed using
Stata (StataCorp, College Station, Tex) and a P value of
.05 was considered significant.
RESULTS
Sixty patients, 34 females and 26males with a mean age
Fig 3. Femoral crossover bypass. A 59-year-old female w
swelling and venous claudication.A, Venogram demonst
left iliofemoral obstruction.C,Computed tomographic (
prosthetic bypass, left superficial femoral artery (SFA)-gra
on inferior vena cava (IVC) (arrowhead). Also seen is left
patient had minimal swelling and no claudication on follof 43 years (SD, 12.5; range, 16-81), underwent 64 venous eeconstructions for chronic venous obstruction affecting 68
imbs. Four patients were analyzed twice, two patients who
ailed hybrid endovenous therapy and underwent Palma
ypass, one with staged bilateral procedures, and another
ith failed femorocaval bypass who underwent a Palma
rocedure. Thirty-seven procedures were performed in fe-
ales, 27 in males. Mean duration of symptoms was 6
ears; 94% of patients presented with swelling, 90% with
enous claudication, and 84% with both. Active ulcerations
ere present in 12 (19%) and another 12% had healed
lcerations (CEAP class11 was C3 in 30, C4 in 12, C5 in 8,
nd C6 in 12). Median CEAP class was 3.5 (range, 0-6), 26
41%) had obstructive pathophysiology alone, and 59% had
ssociated venous valvular incompetence with reflux. Sev-
istory of deep vein thrombosis (DVT) had severe left leg
a patent inferior vena cava (IVC) with a clip. B,Chronic
enogram at 14 months revealed a patent femorofemoral
eriovenous fistula (AVF) (arrow) and previous Miles clip
vein calcification from chronic obstruction (circle). The
p.ith h
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CT) v
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iliacnty-five percent of the patients had only deep venous
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Volume 53, Number 2 Garg et al 387system involvement; the remaining patients had a combi-
nation of deep and superficial and/or perforator vein in-
volvement (Table 1).
All patients had preoperative contrast abdominal and
pelvic venography (descending lower extremity venogra-
phy and CT/MR venography was used additionally in
some cases), along with either venous duplex scanning or
impedance plethysmography or both. Fifteen patients who
underwent 16 bypass procedures had a previously inserted
vena cava interruption device; in 10, the IVC thrombosis
included the segment where the filter was positioned and
possibly contributed to the venous obstruction. All but five
patients had postthrombotic syndrome with either a docu-
mented history of deep venous thrombosis (DVT) or evi-
dence of previous DVT on preprocedure imaging studies.
Three patients had retroperitoneal fibrosis causing obstruc-
tion without thrombosis; three had iatrogenic traumatic
occlusions (two operative deep vein ligations and one with
repeated venous access in childhood for cardiac problems
leading to chronic thrombosis and obstruction). Twenty-
one (25%) patients had history of trauma leading to deep
vein thrombosis. Eighty-four percent of the patients were
Fig 4. Femorocaval bypass. A 42-year-old male presente
more prominent on left side. He had a posttraumatic deep
was placed, leading to IVC and bilateral iliofemoral obstr
and stenting.B, Intraoperative image showing large subcu
femoral-infrahepatic IVC bypass was performed with
arteriovenous fistula (AVF), marked with silastic sheath
months revealed a patent bypass. Previous IVC filter is
residual symptoms at last follow-up. Reproduced with pcompliant with compression therapy at different time inter- eals, and these presented as failures of conservative manage-
ent. Twenty procedures (31%) were performed after
ailed endovascular treatments, 11 of these had more than
ne attempt and one patient had at least three failed endo-
ascular procedures. Seven patients (11%) had failed open
econstructions.
Multilevel obstruction was present in most patients
Table 2). Intraoperative arteriovenous fistula (AVF) was
erformed during the initial procedure in 26 (40.6%) pa-
ients and during reoperation for graft failure in eight
12.5%) patients to increase graft flow.
Early results. There was no mortality and no patient
uffered pulmonary embolism. Twenty-seven early opera-
ive complications were noted in 23 of 64 procedures (36%)
nd included 13 of 64 (20%) early graft occlusions, for an
arly graft failure rate of 17% after OSR (9/52) and 33%
fter HR (4/12). Additional complications included super-
cial wound infections in two, lymphocele in three patients,
eep wound infection and wound hematoma (requiring
urgical drainage) in two patients each, and subcapsular
iver hematoma in one patient.
Eleven of 13 patients with early thrombosis underwent
h history of leg ulcers, swelling, and venous claudication,
thrombosis (DVT), and an inferior vena cava (IVC) filter
n. A, Venogram demonstrated failed venous angioplasty
ous venous collateral due to chronic obstruction.C, Left
m ringed polytetrafluoroethylene (PTFE) and a left
ow). D, Computed tomographic (CT) venogram at 7
proximal to occluded stents. The patient had minimal
sion of the Mayo Clinic.d wit
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February 2011388 Garg et alsion of the graft or the stented vein segment, with a
discharge patency of 96% after OSR and 92% after HR.
Two patients refused reintervention and one graft occluded
intraoperatively despite revision. Two early occlusions were
caused by technical failures and these included a graft
compression in the tunnel in one patient and compression
of the graft by a groin hematoma in another.
All patients except one were discharged on therapeutic
anticoagulation (warfarin, with bridging heparin, if needed).
Pneumatic compression therapy was used perioperatively in
all patients. One patient with early failure, who refused
reintervention, was not discharged on anticoagulation. An-
ticoagulation with warfarin was continued indefinitely in
patients with underlying hypercoagulable disorder and in
all patients with prosthetic bypass.
Late results. Twenty-one patients could not be con-
tacted at last follow-up including six who died (follow-up
data were complete on five of these). Median follow-up on
15 of 60 patients (25%) who were lost for follow-up was 8
months (range,1-61 months). Overall median follow-up
was 41 months (15 days-21 years). Twenty (33%) of the 61
Fig 5. Complex venous reconstruction. A 61-year-old m
vena cava (IVC) filter presented with severe bilateral swel
occluded IVC filter (arrow) and IVC and bilateral iliac a
stents. B, Proximal and C, distal anastomosis of the left
polytetrafluoroethylene (PTFE). D, An interposition PT
performed. E, Computed tomographic (CT) venogram
filter (arrowhead). Reproduced with permission of the Mgrafts patent at discharge occluded, of which five (25%) mere successfully salvaged over long term. On Kaplan-
eier analysis, primary, primary assisted and secondary
atency of all grafts at 5 years was 42% (CI, 29%-56%), 47%
CI, 33%-61%), and 59% (CI, 42%-72%), respectively, and
t 10 years was 33% (CI, 19%-49%), 41% (CI, 25%-57%),
nd 53% (CI, 33%-68%) (Fig 7).
Cumulative patency of the three most common OSR
roups is shown in Fig 8. Complex OSRs and hybrid
rocedures had 28% and 30% 2-year secondary patency,
espectively. Prosthetic femoral crossover bypasses (n  4)
ad a 50% 1-year secondary patency rate.
On univariate analysis, type of bypass significantly
ffected primary (P  .01) and secondary patency rate
P  .01). Patients with chronic venous obstruction that
eveloped due to May-Thurner syndrome had a secondary
atency rate of 32% at 1 year compared with 77% in those
ithout (P  .07). Use of prosthetic conduit decreased
-year patency rate from 81% to 64% (P  .29). AVF
ormation at the initial procedure decreased primary (rela-
ive risk [RR], 1.9; P  0.09) and secondary patency rate
RR, 2.4; P  .11) among OSR cases (Table 3). On
with previous deep vein thrombosis (DVT) and inferior
nd venous claudication. A, Venogram revealed partially
ht femoral obstruction, with occluded bilateral venous
nal iliac vein (EIV) to IVC bypass with 14 mm ringed
raft to right femoral vein from IVC-left EIV graft was
at 2 months revealed patent bypass and previous IVC
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Volume 53, Number 2 Garg et al 389significantly decreased primary (hazard ratio, 3.3; P .01)
and secondary patency (hazard ratio, 6.4; P  .01).
Subgroup analysis
Palma vein procedures. The 5-year primary and sec-
ondary patency was 70% (CI 48%-85%) and 78% (CI 55%-
90%), respectively (Fig 9). The endoscopic vein harvest
(EVH) (n 10) group had lower primary patency (44% vs
86% at 1 year; RR, 4.9; P .04) compared with open group
(n  15), although secondary patency in EVH group was
65% at 1 year and was not significantly different than open
harvest group (RR, 1.96; P  .44). On adjusting for
primary AVF, endoscopic vein harvest significantly in-
creased primary failure in comparison to open harvest (RR,
8.8; P  .02). Similar interaction was noted for secondary
patency (RR, 4.3; P .2). Multivariate analysis endoscopic
vein harvest had the same quantitative effect on primary and
secondary patency, although was not significant (P  .1).
Hybrid reconstructions. Hybrid reconstructions in-
cluded nine patients with unilateral common femoral vein
(CFV) endophlebectomy and patch angioplasty with prox-
imal stent placement and three patients with bilateral iliac
stent placement (unilateral phlebectomy and patch).
Among unilateral procedures, the stent was extended into
the CFV patch in four patients and terminated proximal to
Fig 6. Hybrid reconstruction. A 45-year-old male with
with anticoagulation, developed severe postthrombotic s
cava (IVC) and bilateral iliac vein occlusion (A).B, Intrao
femoral vein (CFV). C and D, Bilateral venous stents
repaired with a bovine pericardial patch. E, Completion v
at 11 months revealed an occluded left sided stent, but
recurrence on left but healed with conservative managemthe patch in five patients. tCumulative 2-year primary and secondary patency was
% and 30% (CI, 4%-62%), respectively (Fig 10). All five
atients without CFV stent extension had early failure (four
mmediate occlusions and one at 4 months). Two of these
ad CFV stent extension at time of revision. Two-year
econdary patency in patients with CFV stent extension
n  6) was 67% compared with 0% without CFV stent
n  3) (P  .01).
During follow-up, the femoral arteriovenous fistula was
losed surgically in 11 of the 34 patients, it was only banded
n three, and it was not closed at all in 20 patients. Thirty-
even patients underwent 33 minor and 28 major second-
ry procedures including early and late graft revisions,
stula banding or ligation, and wound explorations.
At median follow-up of 41months, 53% of patients had
o swelling or minimal swelling without any activity limi-
ations, and 39% had severe residual symptoms. Type of
rocedure correlated significantly with residual moderate
r severe symptoms (P  .02). Relative odds of residual
ymptoms were 0.5 in Palma patients, 0 in short bypass
atients, 0.6 in femorocaval bypass patients, 3 in complex
ypass, and 7 in hybrid reconstructions. All patients except
wohadhealingof venous ulcers for a healing rate of 83% at 12
onths after the procedure. These two patients had complex
econstructions and both developed early graft thrombosis
sive idiopathic deep vein thrombosis (DVT), managed
me with nonhealing ulcers on left leg from inferior vena
ive photograph of the chronically occluded left common
placed after CFV endophlebectomy and left CFV was
ram documented a good result. F, Follow-up venogram
iliac and IVC stent remained patent. Patient had ulcer
Reproduced with permission of the Mayo Clinic.exten
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after reconstructions, two after obstruction of bypass and
three with a patent bypass. All patients who had ulcer recur-
rence with patent grafts had associated infrainguinal reflux
with postthrombotic venous obstructions.
DISCUSSION
In patients with chronic thrombotic venous occlusion,
endovascular recanalization is technically successful in 83%
of patients,7 but long-term patency is inferior to that ob-
served after treatment for venous stenosis only.12 Open
surgical venous reconstructions have been used to treat
patients with chronic venous obstruction for over five de-
cades; Palma and Esperon reported on the successful use of
the cross femoral venous bypass in 1960.13 The Palma
procedure has been used with success by others as well,14-16
and in a recent review of about 400 Palma procedures, we
found the range of reported patency rates to be between
70% and 83% at 3 to 5 years.9 Results were the best in
patients with good inflow and no significant infrainguinal
venous obstruction and incompetence. Our current series
shows a 78% patency rate at 5 years with this procedure.9
The Palma procedure has limitations in terms of availability
Table I. Demographic and procedural data for 64 venous
Baseline characteristics
Age in years (mean  SD) 43  12.5
Gender
Male 27 (42%)
Female 37 (58%)
Smokers 22 (34%)
Obesity 37 (58%)
Hypercoagulable disorder 17 (27%)
Duration of symptoms (mean  SD) 6  6 years
CEAP class
Clinical
0-2 2 (3%)
3 30 (47%)
4 12 (19%)
5 (healed ulcer) 8 (13%)
6 (active ulcer) 12 (19%)
Etiology
Secondary 64 (100%)
May-Thurner with thrombosis 9 (14%)
Retroperitoneal fibrosisa 5 (8%)
Congenital (venous hypoplasia)b 3 (5%)
Traumatic vein ligation 2 (3%)
Previous DVT 59 (92%)
Pathophysiology (n  63)
Obstruction alone 26 (41%)
Obstruction  reflux 37 (59%)
AV, Arteriovenous; DVT, deep vein thrombosis.
aThree without DVT.
bAll had DVT.
cLiver hematoma.of adequate size saphenous vein, potential for external Iompression and obstruction and that it cannot be used for
atients with iliocaval or bilateral iliac vein obstruction.17
mall vein graft can lead to residual symptoms even in
resence of a patent bypass. This was evident in three
atients in our series and has also been reported by others.6
Use of prosthetic materials for venous bypass for any-
hing other than IVC reconstructions was confronted with
riticism and condemned due to increased failure rates
ore than two decades ago.18 Our experience with rein-
orced PTFE in central venous reconstruction has been
ncouraging, and PTFE grafts have been frequently em-
loyed by us for replacement of large veins in patients with
oth malignant and benign conditions, with good re-
ults.8,19 Use of prosthetic graft for femoral crossover by-
ass has been advocated by some but has had high failure in
ur experience (50% 1-year secondary patency).9 Overall
rosthetic grafts have lower patency rates than vein con-
uits but long-term results in short iliocaval or femoroiliac
ypass are encouraging. For femorocaval bypass, results are
ess optimal (57% 5-year secondary patency in this series),
ut they still compare favorably to endovenous results,
ince recanalization and stenting of chronic obstruction of
nstructions
Operative details and outcome
Procedure performed
Femoral crossover bypass 29 (45%)
Iliofemoral/iliocaval bypass 8 (13%)
Femorocaval bypass 9 (14%)
Complex bypass 6 (9%)
Hybrid reconstruction 12 (19%)
Conduit used
Prosthetic 24 (38%)
Vein 28 (44%)
Primary AV fistula formation 26 (41%)
All AV fistulae 34 (53%)
Mortality 0
Pulmonary embolism 0
Deep venous thrombosis 0
Early graft thrombosis 13 (20%)
Surgical revision 10
Endovenous recannalization 1
Wound infection 4 (6%)
Deep 2 (3%)
Superficial 2 (3%)
Wound hematoma 2 (3%)
Otherc 1 (1%)
Revision for stenosis 9 (14%)
Open 7
Endovenous 2
Revision for occlusion 6 (9%)
Open 4
Endovenous 2
Fistula takedown or banding 14 (22%)
Vein ablation/avulsions 3 (5%)recoVC in a large series had only a 66% rate of success.20
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Volume 53, Number 2 Garg et al 391The use of a femoral AVF for venous bypass still re-
mains controversial. In our experience, a primary AVF is
associated with decreased primary and secondary patency
rates, although the results were not statistically significant.
Admittedly, a femoral AVF is used in patients with a higher
chance of graft failure due to poor inflow and the use of a
prosthetic graft. Our earlier description and studies by
others do support its use in conjunction with prosthetic
bypasses,21,22 although subgroup analysis in the current
series is limited by the small numbers of patients. It is also
possible that an AVF in autogenous bypass may not be
beneficial.5
We noted an association of May-Thurner syndrome
Table II. Level of venous occlusion in 64 venous
reconstruction procedures
Venous segments Number of procedures
CFV, FV, distal 1
EIV 2
EIV, CFV 2
EIV, CFV, FV 2
EIV, CFV, FV, distal 2
EIV, CFV, FV, DFV, distal 1
CIV 8
CIV, EIV 9
CIV, EIV, CFV 9
CIV, EIV, CFV, FV 9
CIV, EIV, CFV, FV, distal 3
IVC(i), CIV, EIV 1
IVC(i), CIV, EIV, CFV 2
IVC(i), CIVs, EIVs 2
IVC(i), CIVs, EIVs, CFV, FV 2
IVC(i), CIVs, EIVs, CFVs 2
IVC(i), CIVs, EIVs, CFVs, FVs 2
IVC(p), CIVs, EIVs, CFVs, FV, DFV 1
IVC(h), CIVs, EIVs, CFV, FV, distal 1
IVC(h), CIVs, EIVs, CFVs, FV 1
IVC(s), CIV, EIV, CFV 1
IVC(s), CIVs, EIVs 1
CFV, Common femoral vein; CIV, common iliac vein; EIV, external iliac
vein; FV, femoral vein; h, infrahepatic; i, infrarenal; IVC, inferior vena cava;
p, pararenal; s, suprahepatic.
Fig 7. Cumulative 10-year patency of 64 venous reconstructions.with worse patency in our series. On sensitivity and sub- group analysis this holds true across all procedure types and
s unexplained by current available evidence. One explana-
ion is that all our patients had thrombotic complications of
ay-Thurner syndrome and were operated on because of
xtensive chronic venous obstruction.
Use of endoscopic vein harvest was also associated with
oorer short-term patency rate compared with open vein
arvest for Palma procedures. Current evidence from cor-
nary bypass surgery shows that endoscopic vein harvest
ight lead to early graft failure from structural defects
lthough the latest randomized trial challenges this opin-
on.23,24 More interesting was the interaction noted be-
ween placement of a temporary AVF and endoscopic vein
arvest for our Palma procedure group. AVF formation
eemed to be protective against early graft failure in patients
ith endoscopic vein harvest but not in open harvest
ig 8. Cumulative 10-year secondary patency of three main types
f venous bypasses. All standard errors of mean 10% except
alma up to 96 months.
able III. Univariate analysis of factors affecting
econdary patency
ll procedures Palma vein bypasses
ariable RR
P
value Variable RR
P
value
ge 0.99 .95 Age 0.99 .9
ender (male vs
female)
1.56 .3 Gender (male vs
female)
0.88 .9
moking 1.24 .64 Smoking 1.1 .93
ein conduit
(excluding
hybrid)
0.57 .29 Endoscopic vein
harvest
1.96 .44
VF placement
(excluding
hybrid)
2.37 .11 AVF placement 0.83 .85
ay-Thurner
syndrome
2.8 .07 May-Thurner
syndrome
6.7 .04
ype of procedure 1.35 .01
VF, Arteriovenous fistula; RR, relative risk.
igher RR signifies worse patency in this table.roup.
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February 2011392 Garg et alWehave noted good symptomatic outcomes in patients
with open surgical reconstructions. Ulcer healing was bet-
ter than reported outcomes in endovenous group al-
though we had a higher recurrence rate.7 This discrep-
ancy could be related to possibly more reflux disease in
our patients, since all the ulcer recurrence in patients
with patent grafts was associated with venous reflux. We
noted a higher incidence of active ulceration on presen-
tation in patients with obstruction and reflux compared
with patients with obstruction alone (P  .05), and this
is in agreement with other authors.25
Our overall patency results are comparable to those
reported for endovenous procedures, which have 85% to
100% technical success and 50% to 93% 1-year primary
patency and 75% to 93% 2- to 4-year secondary patency in
different series.12 Complex open and hybrid reconstruc-
tions have the worst outcomes and should be used only as a
last resort. Others have shown similar poor long-term
outcomes with hybrid reconstructions.7 In cases of hybrid
Fig 9. Cumulative 10-year patency of 25 Palma grafts (femoral
crossover bypass with great saphenous vein). Dotted line indicates
standard error of mean 10%.
Fig 10. Cumulative 2-year patency of 12 hybrid reconstructions.
All standard errors of mean 10%.reconstructions, extension of stent into the CFV patch ismportant and significantly improves long-term patency. It
as been shown that stenting across the inguinal ligament is
afe in the venous circulation,26 and it is more harmful to
eave a diseased segment of vein without a stent rather than
tent across the ligament.12
Our study has the limitations of a retrospective study,
lthough only documented imaging patency data were
sed for analysis. Small numbers of patients and the lack of
tandardized outcome analysis in the study, like the venous
linical severity scores, limit rigorous subgroup analysis.
ome patients were lost to long-term follow-up, and some
atients could have been lost in the retrospective database
ut we have no reason to believe that these patients had
ifferent outcomes than the rest of the group.
ONCLUSIONS
Open venous reconstructions should be strongly con-
idered in surgically fit severely symptomatic patients who
ad unsuccessful or failed endovenous treatment for
hronic venous obstructions. Palma vein bypass and il-
ofemoral or iliocaval PTFE bypasses have excellent out-
omes with good symptomatic relief. Hybrid and complex
pen reconstructions have low long-term patency and
hould be used selectively as a last resort.
The authors are grateful to Dr Joseph J Ricotta, II for
is critical revision of the data presentation and contribu-
ion to the manuscript. The authors are also thankful to Mr
tephen Cha from the Division of Biomedical statistics for
is help with analysis.
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